NUCLEOLIN and cancer: Enhanced NCL membrane expression has recently been reported on activated lymphocytes, angiogenic endothelial cells and several types of cancer cells, acting as a binding partner of different molecules implicated in cell differentiation, adhesion, leukocyte trafficking, inflammation, angiogenesis, lymphangiogenesis and tumorigenesis [6, 7].